Profile data is unavailable for this security.
About the company
HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering drug discovery, development, manufacturing and regulatory functions as well as administrative activities to support research and development operations, also covering sales, marketing, manufacturing and distribution of drug developed from research and development activities. The Other Ventures segment is involved in other commercial businesses including the sales, marketing, manufacturing and distribution of other prescription drugs and over-the-counter pharmaceuticals as well as consumer health products.
- Revenue in USD (TTM)838.00m
- Net income in USD100.78m
- Incorporated2000
- Employees1.99k
- LocationHUTCHMED (China) Ltd48Th Floor, Cheung Kong Center2 Queen's Road Central Hong KongHKG
- Phone+852 21281188
- Fax+852 21281778
- Websitehttps://www.hutch-med.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunocore Holdings PLC - ADR | 249.43m | -55.29m | 2.72bn | 497.00 | -- | 7.53 | -- | 10.91 | -1.13 | -1.13 | 4.99 | 7.42 | 0.4439 | 0.3994 | 5.82 | 501,867.20 | -9.84 | -27.55 | -12.51 | -36.82 | 99.58 | -- | -22.17 | -97.12 | 3.77 | -173.40 | 0.1152 | -- | 43.05 | 51.23 | -5.22 | -- | 2.85 | -- |
Arcellx Inc | 110.32m | -70.69m | 2.77bn | 130.00 | -- | 5.60 | -- | 25.12 | -1.49 | -1.49 | 2.30 | 9.28 | 0.1937 | -- | -- | 848,607.70 | -12.41 | -38.82 | -14.67 | -45.41 | -- | -- | -64.08 | -339.38 | -- | -- | 0.0749 | -- | -- | -- | 62.53 | -- | 113.86 | -- |
ACADIA Pharmaceuticals Inc | 726.44m | -61.29m | 2.80bn | 597.00 | -- | 6.48 | -- | 3.85 | -0.3774 | -0.3774 | 4.43 | 2.62 | 1.09 | 1.96 | 9.05 | 1,216,812.00 | -9.17 | -27.50 | -12.81 | -32.73 | 94.27 | 95.62 | -8.44 | -38.35 | 2.28 | -- | 0.00 | -- | 40.45 | 26.55 | 71.62 | -- | 79.52 | -- |
Ideaya Biosciences Inc | 23.38m | -112.96m | 2.80bn | 124.00 | -- | 3.94 | -- | 119.86 | -1.96 | -1.96 | 0.4068 | 9.55 | 0.0451 | -- | 204.23 | 188,580.60 | -21.78 | -19.17 | -23.09 | -21.05 | -- | -- | -483.07 | -244.55 | -- | -- | 0.00 | -- | -54.08 | -- | -92.59 | -- | 6.75 | -- |
Azenta Inc | 641.02m | -17.37m | 2.84bn | 3.50k | -- | 1.16 | 40.62 | 4.43 | -0.2978 | -0.315 | 10.31 | 43.86 | 0.2096 | 2.86 | 3.40 | 183,149.40 | -0.568 | -0.5934 | -0.6169 | -0.6725 | 39.12 | 43.08 | -2.71 | -2.17 | 5.33 | -- | 0.00 | -- | 19.73 | 1.04 | -14.15 | -- | 25.26 | -- |
Apogee Therapeutics Inc | 0.00 | -83.99m | 2.84bn | 91.00 | -- | 6.19 | -- | -- | -1.74 | -1.74 | 0.00 | 7.86 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -111.10 | -- | -- | -- |
Arrowhead Pharmaceuticals Inc | 181.74m | -296.81m | 2.96bn | 525.00 | -- | 16.03 | -- | 16.31 | -2.77 | -2.77 | 1.69 | 1.49 | 0.2395 | -- | -- | 346,171.40 | -39.91 | -20.02 | -46.61 | -24.65 | -- | -- | -166.63 | -61.79 | -- | -55.19 | 0.00 | -- | -1.03 | 71.68 | -16.59 | -- | 162.38 | -- |
HUTCHMED (China) Ltd (ADR) | 838.00m | 100.78m | 2.99bn | 1.99k | 29.49 | 4.04 | 27.38 | 3.57 | 0.5745 | 0.5745 | 4.87 | 4.19 | 0.7258 | 7.19 | 7.69 | 421,528.70 | 8.76 | -- | 13.36 | -- | 54.12 | 36.57 | 12.06 | -31.44 | 2.60 | -- | 0.1038 | -- | 96.52 | 31.38 | 127.93 | -- | 38.65 | -- |
Xenon Pharmaceuticals Inc | 0.00 | -182.39m | 3.02bn | 251.00 | -- | 3.25 | -- | -- | -2.73 | -2.73 | 0.00 | 12.31 | 0.00 | -- | -- | 0.00 | -21.22 | -20.71 | -21.86 | -21.81 | -- | -- | -- | -683.58 | -- | -- | 0.00 | -- | -100.00 | -- | -45.99 | -- | 61.77 | -- |
Iovance Biotherapeutics Inc | 1.19m | -444.04m | 3.16bn | 557.00 | -- | 4.96 | -- | 2,659.17 | -1.89 | -1.89 | 0.0051 | 2.28 | 0.0017 | -- | -- | 2,134.65 | -61.49 | -51.47 | -71.47 | -57.56 | -804.54 | -- | -37,345.42 | -137,873.80 | 2.70 | -- | 0.0017 | -- | -- | -- | -12.16 | -- | 79.44 | -- |
Fortrea Holdings Inc | 3.11bn | -3.40m | 3.17bn | 18.00k | -- | 1.81 | 34.14 | 1.02 | -0.0379 | -0.0379 | 35.03 | 19.58 | -- | -- | -- | 172,722.20 | -- | -- | -- | -- | 16.74 | -- | -0.1094 | -- | -- | 1.27 | 0.478 | -- | 0.4167 | -- | -101.76 | -- | -- | -- |
SpringWorks Therapeutics Inc | 5.45m | -325.10m | 3.18bn | 305.00 | -- | 5.03 | -- | 583.15 | -5.14 | -5.14 | 0.0862 | 8.52 | 0.008 | -- | -- | 17,859.02 | -47.95 | -36.97 | -53.00 | -39.49 | 92.25 | -- | -5,968.50 | -2,176.46 | 6.37 | -- | 0.00 | -- | -- | -- | -17.19 | -- | 90.68 | -- |
Amicus Therapeutics, Inc. | 399.36m | -151.58m | 3.20bn | 517.00 | -- | 19.83 | -- | 8.00 | -0.5148 | -0.5148 | 1.35 | 0.5456 | 0.5318 | 0.8939 | 5.19 | 772,448.80 | -20.18 | -30.65 | -25.36 | -36.55 | 90.65 | 88.94 | -37.96 | -86.10 | 2.52 | -1.76 | 0.7077 | -- | 21.30 | 34.35 | 35.92 | -- | 3.36 | -- |
Holder | Shares | % Held |
---|---|---|
Schroder Investment Management (Hong Kong) Ltd.as of 31 Dec 2023 | 2.09m | 1.20% |
Schroder Investment Management (Singapore) Ltd.as of 31 Dec 2023 | 2.09m | 1.20% |
Allianz Global Investors Asia Pacific Ltd.as of 31 Dec 2023 | 1.47m | 0.85% |
Bellevue Asset Management AGas of 31 Dec 2023 | 1.13m | 0.65% |
Slater Investments Ltd.as of 28 Feb 2023 | 804.35k | 0.46% |
Jane Street Capital LLCas of 31 Dec 2023 | 520.71k | 0.30% |
Acadian Asset Management LLCas of 31 Dec 2023 | 488.91k | 0.28% |
Millennium Management LLCas of 31 Dec 2023 | 391.86k | 0.23% |
AIA Investment Management Pte Ltd.as of 31 Dec 2023 | 391.28k | 0.23% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 348.77k | 0.20% |